Bio Pharma Dive
JANUARY 17, 2025
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
XTalks
JANUARY 17, 2025
Johnson & Johnson (J&J) has announced its $14.6 billion acquisition of Intra-Cellular Therapies, which brings Caplyta (lumateperone) to its growing portfolio of mental health treatments. The deal also includes a cash payment of $132 per share for all outstanding shares of Intra-Cellular Therapies. Caplyta is an oral medication that was first approved in 2019 for the treatment of schizophrenia in adults, followed by a 2021 approval for depressive episodes associated with bipolar I and II
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JANUARY 17, 2025
Shionogis S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao via Getty Images.
ACRP blog
JANUARY 17, 2025
The adoption of the ICH E6(R3) Guideline for Good Clinical Practice marks a defining moment in the evolution of clinical trial execution. As someone committed to advancing quality and innovation in clinical research, I see this milestone as an opportunity for our field to grow and adapt in meaningful ways. ICH E6(R3) isnt just an updateits a call to action.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
JANUARY 17, 2025
A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.
Intouch Solutions
JANUARY 17, 2025
In a recent article published by Med Ad News , Mary Anderson, Senior VP, Managing Director and Head of MedComm at EVERSANA INTOUCH, highlighted the pivotal role medical communications (MedComm) has played in giving brands a leg up in a competitive market. MedComms ability to leverage nonclinical trial data, including patient real-world evidence (RWE) and channel effectiveness analytics, is transformative for brands, especially in rare diseases.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Medical Xpress
JANUARY 17, 2025
Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection.
Pharmaceutical Technology
JANUARY 17, 2025
IMPACT Therapeutics has received the China NMPA marketing authorisation for Senaparib capsules in treating ovarian cancer.
Medical Xpress
JANUARY 17, 2025
Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood clotting in sepsis, a life-threatening condition that causes about 8 million deaths per year.
Pharmaceutical Technology
JANUARY 17, 2025
The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZenecas position in the market.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JANUARY 17, 2025
Hospitals should expand and speed up testing of people hospitalised with influenza to see if they are suffering from bird flu, says CDC.
Pharmaceutical Technology
JANUARY 17, 2025
The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024.
Medical Xpress
JANUARY 17, 2025
A new Health Affairs article highlights the detrimental impact of recent state and federal policies that restrict discussions of "divisive concepts," including structural racism. It warns that these policies undermine efforts to address health inequities and improve population health.
Pharmaceutical Technology
JANUARY 17, 2025
Charles River and Akron Bio have announced the integration of the latters CSS liquid cytokines into the former's Cell Therapy Flex Platform
Medical Xpress
JANUARY 17, 2025
Researchers analyzed the genetic connection of retinal cells and several neuropsychiatric disorders. By combining different datasets, they found that schizophrenia risk genes were associated with specific neurons in the retina. The involved risk genes suggest an impairment of synapse biology, so the ability of neurons to communicate with each other.
Pharmaceutical Technology
JANUARY 17, 2025
Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism remains.
Drug Channels
JANUARY 17, 2025
Todays guest post is from Dorothy Gemmell, Chief Commercial Officer and President, Manufacturer Solutions, at GoodRx. Dorothy highlights five trends to watch in 2025. She then describes how GoodRx's Cash Point-of-Sale Solution can help brands improve gross-to-net (GTN) while also making medications more affordable for patients. Click here to download the latest GoodRx data on copay, cash, and patient services programs.
Pharmaceutical Technology
JANUARY 17, 2025
How longitudinal, closed claims data is advancing regulatory, epidemiology, and health economics and outcomes research (HEOR).
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Medical Xpress
JANUARY 17, 2025
Despite the success cardiac rehabilitation has shown at reducing heart-related deaths and hospital readmissions, higher out-of-pocket costs may prevent patients from participating in the program, a Michigan Medicine study suggests.
Pharmaceutical Technology
JANUARY 17, 2025
The CDE of China's NMPA has granted BTD to Innovent Biologics' IBI343 as a monotherapy treatment for CLDN18.2-positive PDAC patients.
Medical Xpress
JANUARY 17, 2025
Trained health care professionals (THCPs), including medical assistants, respiratory therapists, and nurses, with artificial intelligence (AI) assistance can achieve lung ultrasound (LUS) images with diagnostic quality that does not differ significantly from that achieved by experts, according to a study published online Jan. 15 in JAMA Cardiology.
Pharmaceutical Technology
JANUARY 17, 2025
The metaverse hype is over, but developer Cassette Group has been working with Pfizer to realise its forgotten potential.
Medical Xpress
JANUARY 17, 2025
Bone pain. Joint pain. Bone swelling. These are symptoms that about 1,000 people in the United States begin to feel each year shortly before being diagnosed with osteosarcoma, a type of cancer that starts in the bones. Although any age can develop osteosarcoma, approximately half of diagnosed cases are in children and adolescents.
Pharmaceutical Technology
JANUARY 17, 2025
The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.
pharmaphorum
JANUARY 17, 2025
Boehringer Ingelheim's bid to develop the first drug therapy for impaired cognitive function in schizophrenia looks like it has reached an end.
Pharmaceutical Technology
JANUARY 17, 2025
Discover the leading sales intelligence tools & solutions for the pharmaceutical industry. Download the free Buyer's Guide for contact details.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Medical Xpress
JANUARY 17, 2025
A new study shows that screenings of a locally-produced narrative film about parenting led to a significant reduction in physical violence against children.
pharmaphorum
JANUARY 17, 2025
An AI can identify women who are at risk of experiencing a severe decline in cognitive function in menopause, which can be a risk factor for dementia.
Medical Xpress
JANUARY 17, 2025
Megakaryocytes (MKs), known for their role in platelet production, have emerged as critical players in immune responses, showcasing versatility in both physiological and pathological contexts. Recent advances in technology have unveiled the diverse immune functions of MKs, which express immune sensors and participate in immune activities, thus expanding their traditional role beyond hemostasis and coagulation.
pharmaphorum
JANUARY 17, 2025
AstraZeneca's BTK inhibitor Calquence is the first drug in the class to be approved in the US for first-line treatment of mantle cell lymphoma.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
286 
Let's personalize your content